By Timothy L. Bowen, PhD, New England Biolabs;
and Catherine Blake, Deborah R. Cohen, and Kieron Walsh, GE Healthcare. Corresponding author: Ms. Catherine Blake, Product Specialist – Filtration.
The Focus You've Wanted with The Network You've Needed
The ISBioTech Annual Meeting program for April 2011 is already beginning to fill up. We’re working together with a number of technology experts to recruit the most relevant presentations and posters. Submit your abstract right away to email@example.com.
The Amaxa® Nucleofector® Technology, a non-viral transfection method for primary cells
and hard-to-transfect cell lines, is now lifted to the next dimension with its new platform. The 4D-Nucleofector® System is designed for maximum flexibility and enables Nucleofection® of cells in several formats combined with advanced performance and convenience.
Fast - Different throughput, from one to 16 wells in 10 seconds Easy - Novel technology for transfection of various cell numbers with same conditions Future-proof - Modular system for upcoming transfection challenges Flexible - Nucleofection of cells in adherence for functional assays at various cellular stages Find our more by clicking on this Lonza link.
Advertising & Media
Please contact us to obtain a quote for advertising, or to learn how you can become a sponsor.
To view ad sizing specs, click here.
Don't finalize your media plans for the upcoming year without consulting our all-new media kit first! Request a copy by emailing firstname.lastname@example.org.